Literature DB >> 34236821

Long Noncoding RNA AF131217.1 Regulated Coronary Slow Flow-Induced Inflammation Affecting Coronary Slow Flow via KLF4.

Haibing Jiang1, Zhengrong Ge1, Lijing Zhang1, Yi Yang1, Xueqin Zhai1, Zhanxi Chen1, Qing Wei1.   

Abstract

INTRODUCTION: This study investigated the correlation between the levels of long noncoding ribonucleic acids (lncRNAs) AF131217.1 and coronary slow flow (CSF).
METHODS: A total of 22 patients in the high-sensitivity C-reactive protein (hsCRP) group diagnosed with CSF from January 2018 to December 2018 were enrolled in this study. Coronary flow velocity was determined using the thrombolysis in myocardial infarction frame count (TFC) method.
Results: LncRNA AF131217.1 expression in the CSF model was activated. Mean TFC was positively correlated with lncRNA AF131217.1 levels and hsCRP levels. LncRNA AF131217.1 induced inflammation factor levels in the in vitro model. Micro ribonucleic acid (miR)-128-3p is a target spot of lncRNA AF131217.1 on the inflammation in vitro model via Kruppel-like factor (KLF) 4. MiR-128-3p reduced inflammation factor levels (tumor necrosis factor alpha, interleukin [IL]-6, IL-1β, and IL-18).
Conclusion: Thus, lncRNA AF131217.1 promoted inflammation in the regulated CSF via KLF4 by miR-128-3p.

Entities:  

Keywords:  C-Reactive Protein; GKLF protein; Inflammation; Interleukin-18; Interleukin-6; Long Noncoding; MicroRNAs; Myocardial Infarctation; RNA

Mesh:

Substances:

Year:  2022        PMID: 34236821      PMCID: PMC9423803          DOI: 10.21470/1678-9741-2020-0573

Source DB:  PubMed          Journal:  Braz J Cardiovasc Surg        ISSN: 0102-7638


  23 in total

1.  Contemporary Outcomes of Coronary Artery Bypass Grafting Among Patients With Insulin-Treated and Non-Insulin-Treated Diabetes.

Authors:  Zhongmin Li; Ezra A Amsterdam; J Nilas Young; Holly Hoegh; Ehrin J Armstrong
Journal:  Ann Thorac Surg       Date:  2015-08-25       Impact factor: 4.330

Review 2.  Is there a role for HbA1c in predicting mortality and morbidity outcomes after coronary artery bypass graft surgery?

Authors:  Charlene Tennyson; Rebecca Lee; Rizwan Attia
Journal:  Interact Cardiovasc Thorac Surg       Date:  2013-09-10

3.  Elevated preoperative hemoglobin A1c level is predictive of adverse events after coronary artery bypass surgery.

Authors:  Michael E Halkos; John D Puskas; Omar M Lattouf; Patrick Kilgo; Faraz Kerendi; Howard K Song; Robert A Guyton; Vinod H Thourani
Journal:  J Thorac Cardiovasc Surg       Date:  2008-09       Impact factor: 5.209

Review 4.  Acute renal failure after cardiac surgery for carcinoid heart disease: incidence, risk factors, and prognosis.

Authors:  Kevin R Regner; Heidi M Connolly; Hartzell V Schaff; Robert C Albright
Journal:  Am J Kidney Dis       Date:  2005-05       Impact factor: 8.860

5.  Elevated Hemoglobin A1c Is Associated With Lower Socioeconomic Position and Increased Postoperative Infections and Longer Hospital Stay After Cardiac Surgical Procedures.

Authors:  Brooke Finger; Jason Brase; Jianghua He; Will J Gibson; Katy Wirtz; Brigid C Flynn
Journal:  Ann Thorac Surg       Date:  2016-08-21       Impact factor: 4.330

6.  Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting.

Authors:  Anthony P Furnary; Guangqiang Gao; Gary L Grunkemeier; YingXing Wu; Kathryn J Zerr; Stephen O Bookin; H Storm Floten; Albert Starr
Journal:  J Thorac Cardiovasc Surg       Date:  2003-05       Impact factor: 5.209

Review 7.  Reading between the (guide)lines--the KDIGO practice guideline on acute kidney injury in the individual patient.

Authors:  Mark D Okusa; Andrew Davenport
Journal:  Kidney Int       Date:  2013-09-25       Impact factor: 10.612

8.  Short- and medium-term survival following coronary artery bypass surgery in British Indo-Asian and white Caucasian individuals: impact of diabetes mellitus.

Authors:  Leonidas Hadjinikolaou; Michael Klimatsidas; Gabriele Maria Iacona; Tomasz Spyt; Nilesh J Samani
Journal:  Interact Cardiovasc Thorac Surg       Date:  2009-11-16

9.  Glycated Hemoglobin as a Predictor of the Length of Hospital Stay in Patients Following Coronary Bypass Graft Surgery in the Saudi Population.

Authors:  Joud G Almogati; Elnazeer O Ahmed
Journal:  Braz J Cardiovasc Surg       Date:  2019 Jan-Feb

10.  Can Pre-Operative HbA1c Values in Coronary Surgery be a Predictor of Mortality?

Authors:  Bahar Aydınlı; Aslı Demir; Harun Özmen; Özden Vezir; Utku Ünal; Mustafa Özdemir
Journal:  Turk J Anaesthesiol Reanim       Date:  2017-06-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.